Neovascularisation

Neovascularisation refers to the process of new blood vessel formation from pre-existing vessels. This physiological or pathological process is crucial in various aspects of health and disease, playing a significant role in wound healing, tissue repair, and the progression of diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. Neovascularisation is a complex mechanism involving multiple steps and factors, including the activation and proliferation of endothelial cells, which line the interior surface of blood vessels.

Mechanisms of Neovascularisation

Neovascularisation occurs through two main mechanisms: angiogenesis and vasculogenesis.

• Angiogenesis is the process by which new blood vessels form from pre-existing vessels. It is initiated by the degradation of the basement membrane of a parent vessel, followed by the proliferation and migration of endothelial cells to form new capillaries. This process is regulated by a balance between pro-angiogenic and anti-angiogenic factors, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and angiopoietins.

• Vasculogenesis is the formation of new blood vessels from endothelial progenitor cells (EPCs) or angioblasts in the embryo. In adults, vasculogenesis contributes to the formation of new blood vessels during tissue regeneration and in certain pathological conditions.

Pathological Neovascularisation

In diseases such as cancer, diabetic retinopathy, and age-related macular degeneration, neovascularisation can have detrimental effects. In cancer, the growth of new blood vessels supplies nutrients and oxygen to tumors, facilitating their growth and metastasis. In diabetic retinopathy and age-related macular degeneration, abnormal blood vessel growth can lead to vision loss.

Therapeutic Implications

Understanding the mechanisms of neovascularisation has led to the development of therapies targeting this process. Anti-angiogenic drugs, which inhibit the growth of new blood vessels, are used in the treatment of cancer and certain eye diseases. These therapies aim to starve tumors of their blood supply or prevent the abnormal blood vessel growth that leads to vision loss.

Conclusion

Neovascularisation is a fundamental biological process with significant implications for health and disease. While it plays a critical role in tissue repair and regeneration, its aberrant regulation can contribute to the progression of various diseases. Ongoing research into the mechanisms of neovascularisation and its regulation offers hope for new therapeutic strategies to treat diseases characterized by abnormal blood vessel growth.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian